Ligand profile
TES
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: A0A075B6I6
Identifiers
Database identifiers and provenance.
- Ligand ID
TES- PDB
1i9j- UniProt (similar protein)
Q65ZC0- Target protein
- A0A075B6I6
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 37.3
- −1 ≤ LogP ≤ 5 3.88
- MW ≤ 500 Da 288.4
- LogP ≤ 5 3.88
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 0
- TPSA ≤ 140 Ų 37.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C
InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1
MUMGGOZAMZWBJJ-DYKIIFRCSA-NMUMGGOZAMZWBJJ-DYKIIFRCSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ domain
- Source
- PDB
- Binding sites
- PF07686
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand TES →
- PDB RCSB structure 1i9j →
- UniProt UniProt Q65ZC0 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “TES”) →
Other ligands for this protein
Quick navigation to other ligands bound to A0A075B6I6.
PDB 54
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 29
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).